HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Mankind Pharma, Ipca Labs, 3 Others Show Bullish RSI Momentum

Created at 4 Jun · 2:34 AM2 sources↑ Market-relevant2 events
IN SHORT

Mankind Pharma, Ipca Laboratories, Leela Palaces, Eris Lifesciences, and Indian Bank are showing bullish momentum as their Relative Strength Index (RSI) crossed above 50, indicating potential upward price movement.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

50RSI threshold for bullish momentum

Who's Involved

Mankind Pharma
Nifty500 stock showing bullish RSI momentum
Ipca Laboratories
Nifty500 stock showing bullish RSI momentum
Leela Palaces
Nifty500 stock showing bullish RSI momentum
Eris Lifesciences
Nifty500 stock showing bullish RSI momentum
Indian Bank
Nifty500 stock showing bullish RSI momentum

↳ Why This Matters

The bullish RSI crossover for these five Nifty500 stocks indicates a potential shift in market sentiment and could signal upcoming price increases, attracting investor attention to these specific companies.

Key facts

  • Mankind Pharma shows bullish RSI momentum.
  • Ipca Laboratories shows bullish RSI momentum.
  • Leela Palaces shows bullish RSI momentum.
  • Eris Lifesciences shows bullish RSI momentum.
  • Indian Bank shows bullish RSI momentum.
  • The stocks are part of the Nifty500 index.

Five stocks within the Nifty500 index have demonstrated bullish technical indicators, suggesting potential for upward price trends. These stocks include Mankind Pharma, Ipca Laboratories, Leela Palaces, Eris Lifesciences, and Indian Bank. The positive signal comes as their Relative Strength Index (RSI) has moved above the 50 mark, a level often interpreted as a sign of increasing buying momentum and potential for further price appreciation. This technical development places these companies under increased scrutiny for traders and investors looking for short-term opportunities.

Frequently asked questions

Mankind Pharma, Ipca Laboratories, Leela Palaces, Eris Lifesciences, and Indian Bank are showing bullish momentum.

The Relative Strength Index (RSI) crossing above 50 signaled the bullish momentum for these stocks.

An RSI above 50 typically suggests increasing buying momentum and potential for upward price movement.

What Happens Next

01Market participants will monitor the price action of these stocks following the bullish RSI signal.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

4 Jun · 3:21 AM
Mankind Pharma remains on the brokerage radar, joined by Leela Palaces, Eris Lifesciences, Indian Bank, and Ipca Laboratories due to bullish RSI.
Economic Times via PiQSuite
4 Jun · 2:09 AM
Adani Ports, Hindalco, JSW Steel, Mankind Pharma, and CarTrade are among the stocks on brokerages' radar for today's trade.
NDTV via PiQSuite

Sources

T1
Bullish On Adani Ports; Hindalco, JSW Steel, Mankind Pharma; CarTrade On Brokerage Radarm.piqsuite.com
T1
​Ipca Laboratories among 5 stocks showing bullish RSI upswingm.piqsuite.com

Related Stories

SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM
HSBC downgrades EM equities on AI spending fears
8 Jul · 12:04 PM
Goldman Sachs forecasts 50% jump for CATL shares amid energy storage growth
9 Jul · 2:40 AM
Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
Goldman Sachs sees buyout opportunities in Japan, South Korea, Australia
9 Jul · 4:19 AM